Search

everythinglearnresearchcommunity

for

Search:↓

Some blood pressure medications are linked to a higher risk of skin cancer.

New treatments improved blood pressure control in patients with resistant hypertension.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Minoxidil effectively lowers blood pressure in resistant cases, but needs beta-blocker and diuretic support.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Minoxidil effectively treats severe hypertension but has notable side effects.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Finasteride linked to skin inflammation.